Archive
Proactive news snapshot: ECR Minerals, Corero Network Security, Learning Technologies, Next Fifteen Communications …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
Synairgen PLC
LON:SNG
Synairgen PLC is a UK-based respiratory company focused on drug discovery and the development of SNG001 (inhaled interferon beta) as potentially the first host-targeted, broad-spectrum antiviral treatment delivered directly into the lungs for severe viral lung infections.
149 stories · page 6 of 8
Synairgen, Verona Pharma and why DCF analysis doesn't provide the full picture
A valuation model is only as good as the data plugged in (or omitted)
Investments and investor services
Edenville Energy and Vast Resources shares boosted by project updates
A look at some of the biggest risers and fallers in London.
Archive
Proactive news snapshot: Synairgen, Next Fifteen Communications, Connemara Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Synairgen’s lead drug well tolerated so far in phase II trial
The trial is in two parts and after the positive interim safety readout, regulators have given the green light for the second stage to go ahead
Investments and investor services
FTSE 100 closes firmly higher as OPEC agrees to lift output
FTSE 100 closed over 125 points higher at 7,682, while FTSE 250 also gained ground, up 280 points to 21,009
Archive
Proactive news snapshot: Synairgen, Vast Resources, Amryt Pharma …
A glance at some of the day's highlights from the Proactive Investors newswire
Vernalis shares fall as the firm puts itself up for sale, CEO and CFO to depart in September
A look at some of the biggest risers and fallers in London on Thursday
Synairgen primed for a successful year
Chairman Simon Shaw said: "Synairgen ended 2017 in a strong position"
Investments and investor services
FTSE 100 closes higher as Dow Jones climbs after host of data
Britain's blue chip index closed up around seven points, or 0.10%, at 7,139..
Archive
Proactive news snapshot: Touchstone Exploration, Highlands Natural Resources, Anglo Pacific Group, Next 15 Communications …
A glance at some of the day's highlights from the Proactive Investors newswire
Gattaca drops as boss steps down with immediate effect, dividend cover doubled
A look at some of the biggest risers and fallers in the London market on Wednesday
Synairgen says first phase II clinical trial patients have been dosed
Researchers are investigating whether the inhaled interferon beta treatment is able to protect sufferers of chronic obstructive pulmonary disease from the exacerbating effects of illnesses such as flu and the common cold
FTSE 100 closes strongly higher as markets stabilise
The UK blue chip index closed up 138 at 7,279 - above the day’s peak of 7,255.
Synairgen 's new fibrosis collaboration terms will free it to work in other areas
The new terms give it the opportunity to benefit from a partnership across a whole range of fibrosis-focused treatments
Archive
Proactive news snapshot: Synairgen, Iofina, Atlantis Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Scancell Holdings soars after "stunning endorsement" of its ImmunoBody platform
Cancer Research UK was immensely impressed with the company and its technology
Synairgen shoots higher on new terms for fibrosis collaboration
Synairgen will retain a 17% interest in any partnership across all fibrotic indications